Newsroom

Sorted by: Latest

-

ProImmune and the Roslin Institute Collaborate to Advance Animal Health Science

OXFORD, England & EDINBURGH, Scotland--(BUSINESS WIRE)--ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh’s Roslin Institute to advance veterinary immunology research through development and validation of novel species-specific Ankyron® binders. Increased understanding of animal health through the application of ProImmune’s proprietary Ankyron binding technology will enable development of new strategies for pr...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 17.03.2026 FCSG IE00BKPSPT20 1,100,002.00 USD 47,095,060.55 42.814  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.03.2026 FXGB LN IE00BD5HBR05 37,992.00 GBP 748,839.87 26.297  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.03.2026 FTFX IE00BD5HBQ97 63,402.00 USD 1,654,520.43 26.096  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 17.03.2026 FJUL.LN IE000YJBT6I5 100,002.00 USD 2,668,186.98 26.681  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 17.03.2026 FAPR.LN IE000WX2HZQ7 150,002.00 USD 3,693,959.84 24.626  ...
-

ICL Group Opens Specialty Fertilizer Manufacturing Facility in India, Strengthening Supply Security and Advancing Its Growth Strategy

TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the opening of a new specialty fertilizer production facility in Maharashtra, India. The launch comes at a critical time for India, which relies heavily on fertilizer imports and is now facing supply disruptions due to the latest geopolitical instability and the closure of the Strait of Hormuz - a key global shipping corridor. These delays are already affecting fertilizer...
-

Empire Petroleum Announces Participation in Louisiana Oil and Natural Gas Development Program

TULSA, Okla.--(BUSINESS WIRE)--Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, today announced it has elected to participate in a new oil and natural gas development program in Louisiana that represents a meaningful addition to the Company’s ongoing development activities. Empire has completed its due diligence and elected to participate in a three-well...
-

CRH plc UK Regulatory Announcement: Transaction in Own Shares

NEW YORK--(BUSINESS WIRE)--  18th March 2026 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 17th March 2026 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker Wells Fargo Securities, LLC. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest price per shar...
-

GenSight Biologics annonce le règlement-livraison de sa levée de fonds de près de 1,7 millions d’euros

PARIS--(BUSINESS WIRE)--Regulatory News: NE PAS DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, EN AUSTRALIE, AU JAPON ET EN AFRIQUE DU SUD GenSight Biologics (la « Société ») (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), une société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les maladies neurodégénératives de la rétine et les troubles du système nerveux central, annonce le règlem...